obesity drug news today glp-1 october 27 2025

obesity drug news today glp-1 october 27 2025 KFF's survey of Medicaid officials found 16 state Medicaid programs covered GLP-1s for treatment as of 2025. Since then, four states (CA, NH, PA, SC) have ended coverage and NC McKee's proposed FY2027 budget drops

Name: obesity drug news today glp-1 october 27 2025 KFF's survey of Medicaid officials found 16 state Medicaid programs covered GLP-1s for treatment as of 2025. Since then, four states (CA, NH, PA, SC) have ended coverage and NC McKee's proposed FY2027 budget drops
Brand: actil.am
SKU: 18685975802
Price: 25.29 USD
Availability: InStock
Rating: 4.3582 (24 reviews)

SKU: 18685975802

4.4

USD25.29 USD47.29

Pay in 4 interest-free payments of $6.32 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 20 - Aug 25

Description

CMS may extend, modify, or make the coverage permanent based on results, but as currently structured the bridge is an 18-month demonstration program

Tirzepatides newer market entry means payer policies are still evolving, with trends toward expanded obesity coverage over time

Understanding metabolic memory: the prolonged influence of glycemia during the Diabetes Control and Complications Trial (DCCT) on future risks of complications during the study of the epidemiology of diabetes interventions and complications (EDIC)